Stocktoria
Apyx Medical Corp APYX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1983-07-22
Apyx Medical Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $52.8M | $48.1M | $52.3M | $44.5M | $48.5M |
| Gross profit | $33.0M | $29.4M | $33.8M | $29.1M | $33.6M |
| R&D expense | $3.4M | $5.1M | $5.4M | $4.5M | $4.3M |
| SG&A expense | $15.8M | $18.9M | $22.2M | $20.5M | $18.6M |
| Operating income | -$6.4M | -$18.8M | -$17.3M | -$23.6M | -$14.4M |
| Interest expense | — | — | $2.5M | $15,000 | $10,000 |
| Income tax | $270,000 | $252,000 | -$2.4M | $367,000 | $380,000 |
| Net income | -$11.2M | -$23.5M | -$18.7M | -$23.2M | -$15.2M |
| EPS (diluted) | — | — | $-0.54 | $-0.67 | $-0.44 |
| Operating cash flow | -$8.0M | -$18.0M | -$5.2M | -$20.3M | -$10.4M |
| Free cash flow | -$9.1M | -$18.8M | -$5.8M | -$21.3M | -$11.2M |
| Cash & equivalents | $31.7M | $31.7M | $43.7M | $10.2M | $30.9M |
| Inventory | $8.6M | $7.6M | $9.9M | $11.8M | $6.8M |
| Total assets | $66.8M | $64.8M | $79.2M | $51.8M | $68.7M |
| Total liabilities | $52.0M | $50.5M | $52.3M | $14.0M | $14.7M |
| Shareholders' equity | $14.8M | $14.3M | $26.9M | $37.8M | $54.0M |
Source: SEC EDGAR filings · CIK 0000719135 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.